QXQinghe Xing

Qinghe Xing

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qinghe Xing has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Liver transcriptome sequencing contributes to the molecular diagnosis of genetic liver diseases

    by Ye Cheng, Zhong-Die Li, Zhi-Hong Guan, Li Wang, Yi-Ling Qiu, Wei-Yuan Fang, Jing Zhao, Kun Zhang, Jia-Qi Li, Qing-He Xing, et al.

    Background & Aims: Since DNA sequencing alone faces challenges in variant interpretation during genetic diagnosis, RNA sequencing has recently gained attention in resolving these diagnostic gaps. This study aimed to evaluate the advantages of liver tissue RNA sequencing in the diagnosis of genetic liver diseases. Approach & Result: Liver tissue RNA sequencing was performed on 147 patients with prior DNA sequencing. We evaluated the role of RNA sequencing by analyzing aberrant gene expression, splicing, allele-specific expression, transcript-level similarity and mosaic variants. Liver RNA-seq supported the molecular diagnoses in 56 patients diagnosed by DNA sequencing alone. Among 91 previously undiagnosed patients, incorporating RNA sequencing established a diagnosis in 17 (18.68%) patients. Among the 33 patients with indicative clinical phenotypes or prioritized variants, diagnosis was established in 15 (45.45%) patients under the help of RNA sequencing. This improvement was primarily (16/17) driven by the detection of aberrant splicing and allele-specific expression, instead of aberrant expression. RNA sequencing revealed ±50bp of cryptic splicing sites as hotspot regions, characterized allele-specific expression at both the gene and variant levels and revealed shared transcriptomic features in low GGT cholestasis. Conclusions: While DNA sequencing demonstrates superior sensitivity in detecting clinically relevant variants, liver RNA sequencing significantly enhances genetic diagnosis mainly by revealing aberrant splicing and allele-specific expression. These findings suggest that RNA sequencing is an essential complement to DNA sequencing. Export


  • Open Access

    Clinical variables and genetic variants associated with perioperative anaphylaxis in Chinese Han population: A pilot study

    by Zheng Qi, Ye Cheng, Yu Su, Yimeng Qiao, Jin Zhang, Jian-Jun Yang, Qinghe Xing


  • Open Access

    Loci with genome-wide associations with schizophrenia in the Han Chinese population

    by Zhiqiang Li, Yuqian Xiang, Jianhua Chen, Qiaoli Li, Jiawei Shen, Yun Liu, Wenjin Li, Qinghe Xing, Qingzhong Wang, Lei Wang, et al.

    Background: A large schizophrenia genome-wide association study (GWAS) and a subsequent extensive replication study of individuals of European ancestry identified eight new loci with genome-wide significance and suggested that theMIR137-mediated pathway plays a role in the predisposition for schizophrenia.Aims: To validate the above findings in a Han Chinese population.Method: We analysed the single nucleotide polymorphisms (SNPs) in the newly identified schizophrenia candidate loci and predictedMIR137target genes based on our published Han Chinese populations (BIOX) GWAS data. We then analysed 18 SNPs from the candidate regions in an independent cohort that consisted of 3585 patients with schizophrenia and 5496 controls of Han Chinese ancestry.Results: We replicated the associations of five markers (PMIR137target genes. Two loci (ITIH3/4: rs2239547,P=1.17×10–10andCALN1: rs2944829,P=9.97×10–9) exhibited genome-wide significance in the Han Chinese population.Conclusions: TheITIH3/4locus has been reported to be of genome-wide significance in the European population. The successful replication of this finding in a different ethnic group provides stronger evidence for the association between schizophrenia andITIH3/4. We detected the first genome-wide significant association of schizophrenia withCALN1, which is a predicted target ofMIR137, and thus provide new evidence for the associations betweenMIR137targets and schizophrenia.


  • Common genetic variation in CYP1B1 is associated with concentrations of T4, FT3 and FT4 in the sera of polycystic ovary syndrome patients

    by Shien Zou, Qing Sang, Huan Wang, Ruizhi Feng, Qiaoli Li, Xinzhi Zhao, Qinghe Xing, Li Jin, Lin He, Lei Wang

    CYP1B1 encodes an estrogen enzyme that oxidizes 17β-estradiol to 4-hydroxyestradiol. The evidence demonstrates there may be a relationship between CYP1B1 and thyroid function. To date, no study has evaluated if genetic polymorphisms that regulate concentrations of serum FT3 and FT4 contribute to Polycyctic Ovary Syndrome (PCOS). To identify polymorphisms in the CYP1B1 locus associated with PCOS, we genotyped three common polymorphisms across the CYP1B1 locus in 226 patients. A test for association of common variants with susceptibility to PCOS was conducted in a large cohort of 609 subjects. The functional polymorphism CYP1B1 L432V (rs1056836) is associated with serum T4 (P = 0.003), serum FT3 (P < 0.001) and serum FT4 concentrations (P < 0.001). Our study provides the first evidence that genetic variants in CYP1B1 can be associated with serum T4, FT4 and FT3 levels in PCOS. These findings imply novel pathophysiological links between the CYP1B1 locus and thyroid function in PCOS.


  • Open Access

    Methylenetetrahydrofolate reductase gene polymorphisms and cerebral palsy in Chinese infants

    by Xiuyong Cheng, Tongchuan Li, Honglian Wang, Dengna Zhu, Caiyun Ma, Bingxiang Ma, Yinghong Wang, Junyu Zhang, Luo Guo, Lei Wang, et al.

    Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) have been suggested as being associated with cerebral palsy (CP) but the evidence is uncertain. The purpose of this study was to investigate whether MTHFR gene polymorphisms contribute to the development of CP in Chinese infants. For this study, 169 health controls and 159 infants with CP including 43 cases also suffering from mental retardation (MR) were recruited. Genomic DNA was prepared from venous blood and all five single nucleotide polymorphisms in MTHFR (rs4846049, rs1476413, rs1801131, rs1801133 and rs9651118) were genotyped using TaqMan technology. There were no significant differences in allele or genotype frequencies between the CP patients and controls at any of the five genetic polymorphisms. Subgroup analysis found statistically significant difference in allele and genotype frequencies between cases with both CP and MR (CP + MR) compared with both CP-only cases and controls at rs4846049, rs1476413 and rs1801131. The frequencies of the T alleles of rs4846049, rs1476413 and the G allele of rs1801131 were greater in the CP + MR patients than in the CP-only patients and controls. This study provides the first evidence pointing to a MTHFR gene polymorphism as a potential risk factor for CP combined with MR.